TIME-COURSE AND DETERMINANTS OF SPASTICITY DURING THE FIRST SIX MONTHS FOLLOWING FIRST-EVER STROKE

被引:133
作者
Lundstrom, Erik [1 ,3 ]
Smits, Anja [1 ]
Terent, Andreas [2 ]
Borg, Jorgen [3 ]
机构
[1] Univ Uppsala Hosp, Dept Neurosci, SE-75185 Uppsala, Sweden
[2] Univ Uppsala Hosp, Dept Med Sci, Stroke Unit, SE-75185 Uppsala, Sweden
[3] Karolinska Inst, Danderyd Hosp, Dept Clin Sci, Stockholm, Sweden
关键词
stroke; spasticity; incidence; prevalence; prediction; MODIFIED ASHWORTH SCALE; MUSCLE; RELIABILITY; ASSOCIATION; LIMITATIONS; PREVALENCE; HYPERTONIA; REFLEXES; THERAPY; TRIAL;
D O I
10.2340/16501977-0509
中图分类号
R49 [康复医学];
学科分类号
100232 [康复医学];
摘要
Objective: To explore the occurrence of, and risk factors for, spasticity until 6 months after first-ever stroke. Methods: Forty-nine patients were examined at day 2-10, at 1 month, and at 6 months. The modified Ashworth Scale was used to assess resistance to passive movements. A comprehensive clinical examination was performed to identify other positive signs of upper motor neurone syndrome, in accordance with a broader definition of spasticity, and to evaluate whether spasticity was disabling. Neurological impairments were determined by use of the National Institutes of Health Stroke Scale and global disability by use of the modified Rankin Scale. Results: Spasticity was present in 2 patients (4%) at day 2-10, in 13 patients (27%) at 1 month, and in 11 patients (23%) at 6 months. Severe paresis of the arm at day 2-10 was associated with a higher risk for spasticity at 1 month (odds ratio=10, 95% confidence interval 2.1-48.4). Disabling spasticity was present in one patient at 1 month and in 6 patients (13%) at 6 months. Conclusion: Spasticity according to the modified Ashworth Scale usually occurs within 1 month and disabling spasticity later in a subgroup. Severe paresis of the arm is a risk factor for spasticity.
引用
收藏
页码:296 / 301
页数:6
相关论文
共 32 条
[1]
Baseline NIH Stroke Scale score strongly predicts outcome after stroke - A report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST) [J].
Adams, HP ;
Davis, PH ;
Leira, EC ;
Chang, KC ;
Bendixen, BH ;
Clarke, WR ;
Woolson, RF ;
Hansen, MD .
NEUROLOGY, 1999, 53 (01) :126-131
[2]
AHO K, 1980, B WORLD HEALTH ORGAN, V58, P113
[3]
[Anonymous], 1995, NEW ENGL J MED, V333, P1581, DOI [10.1056/NEJM199512143332401, DOI 10.1056/NEJM199512143332401]
[4]
Barnes S., 1999, PHYSIOTHERAPY, V85, P405, DOI [10.1016/S0031-9406(05)65498-3, DOI 10.1016/S0031-9406(05)65498-3]
[5]
INTERRATER RELIABILITY OF A MODIFIED ASHWORTH SCALE OF MUSCLE SPASTICITY [J].
BOHANNON, RW ;
SMITH, MB .
PHYSICAL THERAPY, 1987, 67 (02) :206-207
[6]
MEASUREMENTS OF ACUTE CEREBRAL INFARCTION - A CLINICAL EXAMINATION SCALE [J].
BROTT, T ;
ADAMS, HP ;
OLINGER, CP ;
MARLER, JR ;
BARSAN, WG ;
BILLER, J ;
SPILKER, J ;
HOLLERAN, R ;
EBERLE, R ;
HERTZBERG, V ;
RORICK, M ;
MOOMAW, CJ ;
WALKER, M .
STROKE, 1989, 20 (07) :864-870
[7]
Burke D, 1988, Adv Neurol, V47, P401
[8]
Theoretical and methodological considerations in the measurement of spasticity [J].
Burridge, JH ;
Wood, DE ;
Hermens, HJ ;
Voerman, GE ;
Johnson, GR ;
Van Wijck, F ;
Platz, T ;
Gregoric, M ;
Hitchcock, R ;
Pandyan, AD .
DISABILITY AND REHABILITATION, 2005, 27 (1-2) :69-80
[9]
THE LIMITATIONS OF THE TENDON JERK AS A MARKER OF PATHOLOGICAL STRETCH REFLEX ACTIVITY IN HUMAN SPASTICITY [J].
FELLOWS, SJ ;
ROSS, HF ;
THILMANN, AF .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1993, 56 (05) :531-537
[10]
Consensus panel guidelines for the use of intrathecal baclofen therapy in poststroke spastic hypertonia [J].
Francisco, Gerard E. ;
Yablon, Stuart A. ;
Schiess, Mya C. ;
Wiggs, Laura ;
Cavalier, Steven ;
Grissom, Samuel .
TOPICS IN STROKE REHABILITATION, 2006, 13 (04) :74-85